Vitamin D3 Neuroprotection Against Rotenone and MPTP in SH‐SY5Y Cells
Basic & Clinical Pharmacology & Toxicology · 2026-06 · 138 (6)
DOI: 10.1111/bcpt.70237 ↗At a glance
Journal article in Basic & Clinical Pharmacology & Toxicology, published online on 2026-05-04. Written by Ekramy M Elmorsy and 7 co-authors. Institution: Center for Health Research, Northern Border University, Arar, Saudi Arabia. Major MEDLINE topics: Rotenone, Neuroprotective Agents, Cholecalciferol, Neurons. 89 references. Funded by: Northern Border University.
Abstract (original language)
Environmental neurotoxicants such as rotenone (RO) and 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) are known to induce cytotoxicity in neural cells. This study aimed to investigate the neuroprotective properties of active vitamin D3 against the cytotoxic effects of RO and MPTP on undifferentiated human neuroblastoma (SH‐SY5Y) cells. Exposure to these neurotoxins resulted in concentration‐ and time‐dependent reductions in cell viability. Cotreatment with vitamin D significantly mitigated the cytotoxic impact of both compounds. Furthermore, vitamin D attenuated disruptions in noradrenaline turnover and acetylcholinesterase activity caused by neurotoxin exposure. Mechanistic exploration revealed that vitamin D preserved cellular bioenergetics by maintaining ATP levels, supporting Mitochondrial Complexes I and III activities, stabilizing mitochondrial membrane potential and reducing lactate accumulation. Vitamin D also reduced oxidative stress, as evidenced by lower reactive species production and lipid peroxidation, while enhancing catalase (CAT) activity in treated cells. In addition, vitamin D counteracted the upregulation of neurodevelopmental genes CAMK2A and CAMK2B induced by neurotoxin exposure. Collectively, these findings demonstrate that vitamin D3 confers significant neuroprotection against RO‐ and MPTP‐induced toxicity in SH‐SY5Y cells by modulating mitochondrial function, oxidative stress and neurochemical balance. These results support the potential therapeutic use of vitamin D3 to prevent or ameliorate neurodegenerative conditions and other neurological disorders characterized by mitochondrial dysfunction and oxidative damage.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Center for Health Research, Northern Border University, Arar, Saudi Arabia.
- Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.
- Experimental Biochemistry Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
- Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
- Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
- Department of Cardiovascular Perfusion, Upstate Medical University, New York, New York, USA.
ORCID profiles: Ekramy M Elmorsy, Ayat B Al-Ghafari, Huda A Al Doghaither, Nagwa M Aly, Mai A Salem, Eman A Toraih, Manal S Fawzy, Shaimaa A Shehata
Funding
- Northern Border University
Cite
APA
Elmorsy, E. M., Al-Ghafari, A. B., Al Doghaither, H. A., Aly, N. M., Salem, M. A., Toraih, E. A., Fawzy, M. S., & Shehata, S. A. (2026). Vitamin D3 Neuroprotection Against Rotenone and MPTP in SH‐SY5Y Cells. Basic & Clinical Pharmacology & Toxicology, 138(6). https://doi.org/10.1111/bcpt.70237
Vancouver
Elmorsy EM, Al-Ghafari AB, Al Doghaither HA, Aly NM, Salem MA, Toraih EA, et al. Vitamin D3 Neuroprotection Against Rotenone and MPTP in SH‐SY5Y Cells. Basic & Clinical Pharmacology & Toxicology. 2026;138(6). doi:10.1111/bcpt.70237
BibTeX
@article{Elmorsy2026,
author = {Elmorsy, Ekramy M and Al-Ghafari, Ayat B and Al Doghaither, Huda A and Aly, Nagwa M and Salem, Mai A and Toraih, Eman A and Fawzy, Manal S and Shehata, Shaimaa A},
title = {Vitamin D3 Neuroprotection Against Rotenone and MPTP in SH‐SY5Y Cells},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2026},
volume = {138},
number = {6},
doi = {10.1111/bcpt.70237}
}
EUVIMED